Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 15.15% is 372% above its 3-year average of -5.57%, near the high end of its 3-year range (-413.85%–97.97%).
121.25% above its 12-month average of -71.29%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 20.53%.
NET PROFIT MARGIN
15.15%
NET PROFIT MARGIN AVG TTM
-71.29%
NET PROFIT MARGIN AVG 3Y
-5.57%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+121.25%
CURRENT VS 3Y AVG
+371.85%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 102 covered companies
CURRENT VS SECTOR MEDIAN
+74.54%
vs the sector median at left
Hinge Health, Inc.
Market Cap
$7.56B
Net Profit Margin
15.15%
TTM Avg
-71.29%
3Y Avg
-5.57%
5Y Avg
N/A
Market Cap
$8.02B
Net Profit Margin
3.60%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$6.63B
Net Profit Margin
10.60%
TTM Avg
11.45%
3Y Avg
11.66%
5Y Avg
12.42%
Market Cap
$6.47B
Net Profit Margin
-5.51%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$5.61B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
Market Cap
$9.67B
Net Profit Margin
2.96%
TTM Avg
3.05%
3Y Avg
3.43%
5Y Avg
3.79%
Market Cap
$5.35B
Net Profit Margin
-3368.72%
TTM Avg
-8808.10%
3Y Avg
-41695.11%
5Y Avg
-35876.65%
Market Cap
$5.22B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hinge Health, Inc. (HNGE) | $7.56B | 15.15% | -71.29% | -5.57% | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.02B | 3.60% | -1.75% | -5.71% | -20.27% |
| Chemed Corporation (CHE)vs › | $6.63B | 10.60% | 11.45% | 11.66% | 12.42% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.47B | -5.51% | 7.00% | -0.29% | -8.82% |
| Insulet Corp. (PODD)vs › | $9.12B | 12.29% | 14.66% | 10.46% | 7.35% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.61B | 0.00% | 0.00% | -101.30% | -277.86% |
| Henry Schein, Inc. (HSIC)vs › | $9.67B | 2.96% | 3.05% | 3.43% | 3.79% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.35B | -3368.72% | -8808.10% | -41695.11% | -35876.65% |
| Doximity, Inc. (DOCS)vs › | $5.22B | 25.48% | 34.77% | 31.87% | 32.80% |
| Molina Healthcare, Inc. (MOH)vs › | $9.89B | -0.02% | 1.97% | 2.41% | 2.58% |
Operating Margin
-92.9%
Net Profit Margin
15.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 20.53% |
| 2026-03-31 | 19.27% |
| 2025-12-31 | 18.80% |
| 2025-09-30 | -1.20% |
| 2025-06-30 | -413.85% |
| 2025-03-31 | 97.97% |
| 2024-12-31 | 23.13% |
| 2024-09-30 | 0.34% |
| 2024-06-30 | -14.39% |
| 2024-03-31 | -32.00% |
| 2023-12-31 | -29.58% |
| 2023-09-30 | -20.61% |
| 2023-06-30 | -45.59% |
